Regulation & law · 25/09/2009Updated: 10/17/2026 · 1 min read
Genova Biotherapeutics Inc. Halts Trading Amid Regulatory Issues
Summary
Genova Biotherapeutics Inc. has suspended trading due to regulatory concerns, leaving investors uncertain about the company's future.
Original source language: Federal Register — All DocumentsOpen original release →